Search for: "Patent Docs"
Results 781 - 800
of 1,613
Sort by Relevance
|
Sort by Date
27 Mar 2011, 11:12 pm
Patent and Trademark Office (Patent Docs) Post-grant review provisions of S. 23 (Patent Docs) Additional opportunities for pre- and post-grant review, and brand new patent trial and appeal board in S. 23 (Patent Docs) Few ‘reform’ provisions remain in S. 23 relating to the judiciary (Patent Docs) Disappearance of deceptive intent in S. 23 (Patent Docs) US Patents Judge… [read post]
22 Mar 2011, 4:21 pm
Antibodies’ (Patent Docs) US: Bayh-ing for blood? [read post]
21 Mar 2011, 3:06 am
(Patent Docs) Inventor’s interests, if not rights, limited by S. 23 (Patent Docs) US Patents USPTO to reset patent re-examination dates for earthquake victims (Patents Post Grant Blog) False marking settlement updates (Patently-O) White House issues proposals for IP legislation (IP Watch) Who is suing for patent infringement? [read post]
18 Mar 2011, 10:01 pm
(Patent Docs) (IPBiz) (IP Whiteboard) (Patent Docs) (Inventive Step) (IP Spotlight) (Blawg IT) (Patents Post-Grant) (Patent Law Practice Center) US proposals for IP in the Trans-Pacific Partnership leaked / ???????????????????????? [read post]
16 Mar 2011, 4:02 am
Doc. 960 (Fed. [read post]
16 Mar 2011, 3:50 am
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
15 Mar 2011, 7:23 am
PATENT AND TRADEMARK (vjk) (Entered: 02/11/2011) 2/11/2011 3 Summons Issued as to Casa de Campo Farallon, S.A., Rugiere Galvez. [read post]
14 Mar 2011, 4:59 am
Highlights this week included: European Court of Justice trashes planned unified patent litigation system : Avis 1/09 (Kluwer Patent Blog) (IAM) (ipeg) (BLOG@IP::JUR) (inovia’s Foreign Filing Blog) (Kluwer Patent Blog) (IP Spotlight) (PatLit) (IPKat) (PatLit) (EPLAW) Senate passes S. 23 (95-5) (Patent Docs) (IPBiz) (IP Whiteboard) (Patent Docs) (Inventive Step) (IP Spotlight) (Blawg IT) (Patents Post-Grant)… [read post]
14 Mar 2011, 1:46 am
[CJEU President Vasilios Skouris] On 8 March the Court of Justice of the European Union (CJEU) handed down its long-awaited opinion on the compatibility of the "Draft Agreement on the European and Community Patents Court" [Doc. 7928/09], which basically expresses the Commission's 2007 vision to replace the EU-independent European Patent Litigation Agreement (EPLA) and implement an EU controlled patent litigation system called European and EU… [read post]
11 Mar 2011, 8:57 pm
(FDA Law Blog) (Patent Docs) Melatonin – EWCA refers SPC questions to the ECJ: Neurim Pharmaceuticals (1991) Ltd v Comptroller General of Patents /???????????? [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject… [read post]
8 Mar 2011, 2:15 am
Today, the European Court of Justice published its opinion (pdf provided by EPALW) on the "Draft Agreement on the European and Community Patents Court" [Doc. 7928/09] (case Avis 1/09) and found, not overly surprising, the Draft Agreement incompatible with the EU Treaty [Doc 9076/09] and EU law. [read post]
7 Mar 2011, 1:35 pm
[EURO coins, permission: ECB/03/4 /5] As reported earlier on this blog, the latest version of the "Draft Agreement on the European and Community Patents Court" [Doc. 7928/09] is subject to an opinion by the European Court of Justice (ECJ) on the compatibility of the envisaged Agreement with the EU Treaty [Doc 9076/09]. [read post]
4 Mar 2011, 9:18 pm
(Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
1 Mar 2011, 8:38 pm
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
27 Feb 2011, 9:49 pm
(IP Spotlight) General – Patents PCT and EP filings on the rise again (Patent Docs) Global – Trade Marks / Brands How does it feel to be commoditised? [read post]
23 Feb 2011, 4:59 am
In videos breathlessly presented throughout the conservative mediasphere this weekend, doctor after doctor is videotaped writing patently fraudulent sick notes so that the protesting teachers (whose contracts specify that missing work without an excuse can result in dismissal) can keep marching on against the state's union-busting Republican government.This raises the question of ethics; whether it's acceptable for physicians to lie for the greater good. [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and pay-for-delay… [read post]
20 Feb 2011, 9:44 pm
§ 112, 2nd Paragraph (Patent Docs) Summary of false marking settlements May – December 2010 (GRAY on Claims) Article One announces $25,000 bonus for 2010 (Article One Partners Blog) Should I request ex parte or inter partes reexamination? [read post]
18 Feb 2011, 9:59 pm
The Symposium, entitled "The Economics of Intellectual Property and Technology," will consist of the following sessions: • Economics of Biotechnology: The Human Gene Patenting Debate -- a panel discussion on the implications of the recent Myriad litigation on the future of gene patents and the development of medical treatments featuring Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; Yvonne Cripps of the University of… [read post]
